fda semaglutide compounding says that the GLP-1 shortage is over altRx GLP-1 Review 2026: Updated

Beyond weight loss, Phase 2 data demonstrated improvements in HbA1c , fasting glucose , triglycerides , blood pressure , and waist circumference all clinically relevant markers in the context of cardiovascular and metabolic risk

Metabolites were identified and quantified using liquid chromatographymass spectrometry (LC-MS)

A 2022 review in Gastroenterology looked at GLP-1 agonist use across multiple trials and found a roughly two-fold increase in acute pancreatitis risk compared to placebo

GLP-1s can be useful tools, but they are not magic

Many Lee's Summit residents find that their insurance covers part of GLP-1 treatment, though it often requires prior authorization